XXII 22nd Century Group Inc.

1.04
-0.02  -2%
Previous Close 1.06
Open 1.01
Price To Book 2.54
Market Cap 139,796,382
Shares 134,419,598
Volume 630,623
Short Ratio 6.91
Av. Daily Volume 2,485,573
Stock charts supplied by TradingView

NewsSee all news

  1. 22nd Century Group Appoints New Director and New Chairman

    Williamsville, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

FDA Tobacco Products Scientific Advisory Committee (TPSAC) to meet February 14, 2020, regarding MRTP application. Ignore "NDA filing" in the "stage" column to the left.
VLN cigarettes
MRTP application

Latest News

  1. 22nd Century Group Appoints New Director and New Chairman

    Williamsville, NY, Jan. 13, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco